This is the authors' abstract. We don't add key points for this paper.
Psoriasis is a chronic inflammatory skin disease that may be triggered or worsened by several factors, including alcohol. A higher than average alcohol consumption is common among individuals with psoriasis. Neurobiological signaling affected by alcohol intake includes a range of neurotransmitters, such as the dopaminergic, serotonergic, and tachykinergic systems, involved in reward and drug-seeking. These neurotransmitters may also have an impact on the inflammatory processes per se in psoriasis. Future therapy may, therefore, be targeted at neurotransmitter networks involved with both alcohol intake and the inflammatory processes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Svanstrom et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: